Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Carillon Eagle Small Cap Growth Fund 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Carillon Eagle Small Cap Growth Fund)

Primary Source Intelligence • Q1 2024 Letter Analysis

Carillon Eagle Small Cap Growth Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Carillon Eagle Small Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+1.41%

Digest Analysis

Quick Take

"Small-cap growth fund delivered strong Q1 performance led by AI infrastructure plays like Super Micro Computer and biotech breakthrough Viking Therapeutics."

Executive Summary

The Carillon Eagle Small Cap Growth Fund posted strong performance in Q1 2024, driven by exposure to AI infrastructure, biotechnology breakthroughs, and energy sector strength. Top contributors included Super Micro Computer, which benefited from AI data center demand, Viking Therapeutics with promising GLP-1 obesity drug results, and Viper Energy from rising oil prices. The fund's 97 holdings reflect a diversified approach to small-cap growth investing. The managers see continued opportunities in AI infrastructure, healthcare innovation as COVID headwinds fade, and industrial companies benefiting from re-shoring trends. Key risks include momentum-driven market volatility, potential interest rate backup, and election uncertainty. The team is actively managing momentum exposure while focusing on companies with durable secular growth prospects. With the Fed likely to cut rates and economic resilience continuing, the outlook remains constructive for small-cap growth stocks with strong fundamentals and exposure to transformative themes like artificial intelligence and biotechnology innovation.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The fund demonstrates moderate-high conviction through concentrated positions in named holdings with detailed thesis explanations. Managers provide specific rationale for top performers like SMCI and VKTX, and decisive selling of underperformers. The 97-holding portfolio with clear sector themes and explicit position management indicates solid conviction, though diversification prevents a higher score.

Growth Outlook

65%

BearishBullish

Bullish (65%)

The managers express a constructive outlook citing economic resilience, subsiding inflation, and favorable Fed positioning. They describe the current environment as a 'sweet spot' for equity returns and expect continued market support from rate cuts. However, they acknowledge risks and uncertainty, preventing a more bullish score.

Risk Appetite

45%

DefensiveAggressive

Balanced (45%)

The fund maintains full investment with 97 holdings but is actively managing momentum exposure and remaining alert to risks. They sold underperforming positions like Wesco and MarketAxess, showing selective risk management rather than aggressive risk-taking or defensive positioning.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

The fund shows modest net deployment activity through selective position additions in AI and biotech themes while selling underperforming positions like Wesco and MarketAxess. This represents rotation and selective deployment rather than significant cash level changes, warranting a slightly positive but low score.

Forward Guidance

55%

CautiousExpansionary

Neutral (55%)

The managers plan to continue focusing on secular growth companies and are monitoring opportunities in AI, healthcare, and industrials. They express intent to find attractive opportunities but emphasize selectivity and risk management rather than aggressive deployment.

Language Signal

50%

BearishBullish

Balanced (50%)

Language is balanced between opportunity-focused terms like 'constructive outlook,' 'attractive opportunities,' and 'strong gains' with risk-aware language including 'risks associated,' 'uncertainty,' and 'actively managing exposure.' The tone is measured rather than directionally biased.

Perceived Risk

55%

Low RiskElevated

Moderate Risk (55%)

The managers identify several specific risks including momentum-driven market volatility, potential interest rate backup, election uncertainty, and inflationary pressures. These risks are discussed with meaningful detail and context, indicating moderate risk awareness without being alarmist.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

The managers see attractive opportunities across multiple sectors including AI infrastructure, healthcare innovation, industrial re-shoring, and energy. They describe specific areas of excitement in technology, financials, and consumer sectors, indicating a relatively rich opportunity set requiring selectivity.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The fund demonstrates a multi-year investment horizon with focus on secular growth themes and companies that can 'outperform over the course of an economic cycle.' While they monitor quarterly results and near-term catalysts, the emphasis on secular trends and cycle-through performance indicates a longer-term orientation typical of growth investing.